Investing.com – Australia stocks were higher after the close on Wednesday, as gains in the Healthcare, Energy and IT sectors led shares higher. At the close in Sydney, the S&P/ASX...
Investing.com – Australia stocks were higher after the close on Tuesday, as gains in the Healthcare, Telecoms Services and Energy sectors led shares higher. At the close in...
Investing.com – Australia stocks were lower after the close on Friday, as losses in the Gold, Materials and Metals & Mining sectors led shares lower. At the close in Sydney, the...
CSL Ltd (AX:CSL) Chart Review CSL Continues Along Long Term Uptrend Towards Record Highs CSL has experienced a phenomenal run in its share price over the last 5 years as the stock...
The fourth estimate of 2015-2016 capital expenditures will be released on Thursday and expectations are for them to increase 4.5% to A$120 billion from the third estimate. This...
Asian markets are clearly unwilling to rally past the recent highs they set last Friday ahead of the Fed and Bank of Japan (BoJ) meetings. Volumes were down dramatically across the...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Buy||Buy||Strong Buy||Buy||Buy|
|Technical Indicators||BUY||Strong Sell||Strong Buy||Strong Buy||Strong Buy|
|Summary||Buy||Neutral||Strong Buy||Strong Buy||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Upside Gap Three Methods||1H||3||Nov 13, 2019 09:00PM|
|Abandoned Baby Bullish||1H||6||Nov 13, 2019 06:00PM|
|Falling Three Methods||1H||8||Nov 12, 2019 11:00PM|
CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies (plasma products and recombinants). The Seqirus segment manufactures and distributes non-plasma biotherapeutic products. Seqirus manufactures, sells and distributes a range of vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand. It also manufactures and markets in vitro diagnostic products through Seqirus immunohematology. The CSL Intellectual Property segment is engaged in licensing of intellectual property generated by the Company to unrelated third parties. The Company has facilities in Australia, Germany, Switzerland, the United Kingdom and the United States.Read More
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.